AbbVie seeks lift from 'guided missile' cancer drug with $10 bln ImmunoGen deal - Reuters
reuters.comSubmitted by reuters8361 in business
AbbVie <a href="https://www.reuters.com/markets/companies/ABBV.N" target="_blank">(ABBV.N)</a> will buy ImmunoGen <a href="https://www.reuters.com/markets/companies/IMGN.O" target="_blank">(IMGN.O)</a> for $10.1 billion in cash, it said on Thursday, the lates…